The SIV-smm-pbj-14 strain is a unique primate lentivirus that encodes a Nef protein containing an immunoreceptor-based tyrosine activating motif (ITAM). This ITAM activates T-cells through interaction with ZAP-70 tyrosine kinase, a key component of the T-cell receptor complex (TCR). The hypothesis for this proposal is that this Nef-ITAM may activate intracellular signal pathways in dendritic cells, and thereby enhance immune stimulation and antigen presentation.
Two Specific Aims address this hypothesis.
Aim 1 describes the construction of various plasmid constructs and adenovirus vectors designed to express several forms of Nef-ITAM together with the target antigen, which is the HIV-1 envelope glycoprotein.
Aim 2 assesses the potential role of the Nef-ITAM on antigen presentation functions in cultures of human and mouse dendritic cells infected with adenovirus vectors. Additional in vivo experiments in mice with the adenovirus vectors test the effects of the Nef-ITAM on immune responses to the envelope glycoprotein.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI046312-02
Application #
6171059
Study Section
Special Emphasis Panel (ZRG1-AARR-2 (01))
Program Officer
Bradac, James A
Project Start
1999-08-01
Project End
2001-12-31
Budget Start
2000-08-01
Budget End
2001-12-31
Support Year
2
Fiscal Year
2000
Total Cost
$238,500
Indirect Cost
Name
University of Rochester
Department
Microbiology/Immun/Virology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Richards, Julie L; Abend, Johanna R; Miller, Michelle L et al. (2003) A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells. Eur J Biochem 270:2287-94
Dewhurst, S L; da Cruz, R L; Whetter, L (2000) Pathogenesis and treatment of HIV-1 infection: recent developments (Y2K update). Front Biosci 5:D30-49